Free Trial

CureVac (CVAC) Stock Forecast & Price Target

$3.72
+0.07 (+1.92%)
(As of 07/18/2024 ET)

CureVac - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 5 Wall Street analysts who have issued ratings for CureVac in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 1 has given a sell rating, 3 have given a hold rating, and 1 has given a buy rating for CVAC.

Consensus Price Target

$10.00
168.82% Upside
High Forecast$18.00
Average Forecast$10.00
Low Forecast$4.00

According to the 5 analysts' twelve-month price targets for CureVac, the average price target is $10.00. The highest price target for CVAC is $18.00, while the lowest price target for CVAC is $4.00. The average price target represents a forecasted upside of 168.82% from the current price of $3.72.

TypeCurrent Forecast
7/19/23 to 7/18/24
1 Month Ago
6/19/23 to 6/18/24
3 Months Ago
4/20/23 to 4/19/24
1 Year Ago
7/19/22 to 7/19/23
Consensus Rating
Hold
Reduce
Hold
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
4 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$10.00$6.00$15.00$19.00
Forecasted Upside168.82% Upside6.76% Upside68.35% Upside114.54% Upside
Get CureVac Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter.

CVAC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CVAC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CureVac Stock vs. The Competition

TypeCureVacMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.71
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside168.82% Upside1,353.19% Upside9.09% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/3/2024JMP Securities
2 of 5 stars
 Reiterated RatingMarket Outperform ➝ Market Outperform$18.00 ➝ $18.00+476.92%
4/25/2024Leerink Partnrs
0 of 5 stars
M. Foroohar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
4/25/2024SVB Leerink
1 of 5 stars
 DowngradeOutperform ➝ Market Perform$12.00 ➝ $4.00+59.36%
4/5/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral
8/21/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderperform ➝ Underperform$10.00 ➝ $8.00-8.36%
6/8/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$13.00+31.05%
1/19/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$18.00+89.87%
1/6/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$21.00+154.24%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 10:01 PM ET.

CVAC Forecast - Frequently Asked Questions

What is CureVac's forecast for 2024?

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for CureVac is $10.00, with a high forecast of $18.00 and a low forecast of $4.00.

Should I buy or sell CureVac stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CureVac in the last twelve months. There is currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CVAC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CVAC, but not buy additional shares or sell existing shares.

Does CureVac's stock price have much upside?

According to analysts, CureVac's stock has a predicted upside of 108.91% based on their 12-month stock forecasts.

Has CureVac been downgraded by Wall Street analysts recently?

Over the previous 90 days, CureVac's stock had 2 downgrades by analysts.

What analysts cover CureVac?

CureVac has been rated by research analysts at JMP Securities, Leerink Partnrs, and SVB Leerink in the past 90 days.

Do Wall Street analysts like CureVac more than its competitors?

Analysts like CureVac less than other "medical" companies. The consensus rating for CureVac is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CVAC compares to other companies.


This page (NASDAQ:CVAC) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners